Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1382_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
11 Мб
Скачать
☆
“This page left intentionally blank.”
34

Laparoscopic Retroperitoneal Adrenalectomy

Shamly V. Dhiman and James A. Lee
Introduction
Laparoscopic adrenalectomy haslargely replaced open adrenalectomy as the preferred method for resection of most adrenal tumors. Adrenocorti­cal cancer and malignant pheochromocytoma remain relative contraindications to this rule. Over the years, many techniques forlaparoscopic adrenalectomy have been developed, including multiple variations on the transabdominal and retroperitoneal approaches (i.e., lateral, supine, prone). The lateral transabdominal approach has become the most widely used technique for laparoscopic adrenalectomy due to the familiar view and well-defined anatomical land­marks while the retroperitoneal approaches fell by the wayside at most centers. However, in recent years a number of advances in the poster­ior retroperitoneal technique have led to a renaissance in the laparoscopic retroperitoneal approach for selected patients.
Since the first case report of successful ret­roperitoneal adrenalectomy in 1994, the tech­nique of this operation has been significantly improved and refined to the point where some authors consider it superior to the lateral transabdominal approach for selected patients [1]. In fact, some institutions use the retroper­itoneal approach as the preferred method of adrenalectomy for most adrenal tumors. In the largest series to date, Walz et al. performed 560 adrenalectomies via this approach in
tumors that spanned the gamut of pathology andsizeupto10cm[2].Intheearlyphasesof development, the main problems with the ret­roperitoneal approach included (1) difficulty creating an adequate working space and (2) lack of traditional landmarks. Many of these issues were solved by optimizing the patient positioning, increasing the retroperitoneal insufflation pressure, and codifying the approach to dissection [3–5]. In particular, the liberal use of insufflation pressures of 12–30 mm Hg have drastically increased the size of the working space and made the opera­tion much simpler.
Benefits of Retroperitoneal Adrenalectomy (Compared to Transabdominal Adrenalectomy)
Reduced Operating Times
Many series have documented that operative times for laparoscopic adrenalectomy by any method have reached parity with open operative times and in most cases have decreased [7–9]. While the duration of operation differs between the left and the right side, the average operative time for a lateral transabdominal approach is approximately 80–120 min. In the largest series of retroperitoneal adrenalectomies, the average operative time was 67 min [2]. When the analy­sis was limited to the most recent operations,
J.G.H. Hubbard et al. (eds.), Endocrine Surgery, Springer Specialist Surgery Series, DOI 10.1007/978-1-84628-881-4_34, Ó Springer-Verlag London Limited 2009
451
452
ENDOCRINE SURGERY
this operative time dropped even further to 40 min, reflecting the steep learning curve of the early years of development. Much of this decrease in operative time between the two methods is due to the direct access to the adre­nal gland in the retroperitoneal technique. With the transabdominal technique, much of the operation is spent mobilizing the abdominal viscera (i.e., liver, spleen, pancreas) just to expose the adrenal gland. In the retroperitoneal approach, the kidney, adrenal gland, and peria­drenal fat are immediately in view with little dissection. In addition, one of the most time­consuming parts of the procedure is proper patient positioning. For cases of bilateral adre­nalectomy, obviating the need to ‘‘flip’’ the patient into the contralateral decubitus position in the lateral transabdominal approach further reduces operating room time. With the retro­peritoneal approach, the patient need only be shifted toward the contralateral side of the table.
Avoidance of Intraabdominal Adhesions and Irradiated Fields
Laparoscopic lateral transabdominal adrena­lectomy is safe and feasible to perform in patients who have had prior abdominal surgery. However, in a large multicenter retrospective analysis there was a trend toward longer opera­tive times in patients with previous upper abdominal surgery [6]. The retroperitoneal technique eliminates the need for lysis of intraabdominal adhesions, further reducing operative time. With the exception of certain urologic procedures, the retroperitoneal planes are seldom affected by previous operations. The same benefit applies for avoiding the desmo­plastic reaction in previously irradiated fields.
Potential Decrease in Postoperative Pain and Incisional Hernia
In general, laparoscopic adrenalectomy has reduced the incidence of complications, length of stay, and severity of postoperative pain when compared to open adrenalectomy [10, 11]. Some authors have suggested that retroperitoneal adrenalectomy yield further decreases in post­operative pain then even the laparoscopic trans­abdominal approach, although this has yet to be proven in a randomized controlled clinical trial [2, 12]. In addition, incisional hernia rates in
laparoscopic transabdominal adrenalectomy depend largely on the pathology and whether or not the surgeon enlarges the fascia at the site of extraction. However, incisional hernias are almost nonexistent with the retroperitoneal approach since the kidney occupies the space throughwhich potential hernias would encroach.
Improved Hemostasis
One of the side benefits of insufflation in a small, closed space is that the increased pressure leads to improved hemostasis. The small venules and arterioles associated with the adrenal gland typi­cally ‘‘auto-tamponade’’ and seal with insuffla­tion pressures alone at pressures of 12–20 mm HG. If there is recalcitrant bleeding, often increasing the insufflation pressure to 25–30 mm Hg will effect hemostasis. In one large series, when a caval injury or adrenal vein injury occurred, increasing the insufflation pres­sure allowed for hemostasis until a definitive solution was accomplished. Of note, there were no instances of gas embolism in this series [6].
Disadvantages of Retroperitoneal Adrenalectomy (Compared with Transabdominal Adrenalectomy)
The main weaknesses of the retroperitoneal approach include a small working space, a per­ceived lack of anatomic landmarks, and the inability to explore the rest of the abdominal cavity. As mentioned previously, using increased insufflation pressures and proper positioning of the patient help to enlarge the limited working space. However, judicious selection of patients based on tumor size is critical. Tumors greater than 7 cm in size should be approached through a transabdominal approach. Perhaps the major drawback for the surgeon just learning the tech­nique of retroperitoneal adrenalectomy is the lack of familiar landmarks, such as the spleen, pancreas,and liver. However, once the surgeon is oriented to the layout of the retroperitoneal space, finding the critical landmarks is straight­forward. The retroperitoneal space is bounded by the peritoneum laterally, paraspinous muscle medially, ribcage posteriorly (i.e., away from the table), and kidney/adrenal gland/peritoneum anteriorly (i.e., toward the table).
453
LAPAROSCOPIC RETROPERITONEAL ADRENALECTOMY
Indications and Contraindications
The indications for laparoscopic retroperitoneal adrenalectomy are generally the same as for laparoscopic transabdominal adrenalectomy. Almost any tumor that can be removed via a transabdominal approach can be removed through the retroperitoneal approach, includ­ing pheochromocytoma and adrenal metastases [2, 13–16]. Relative contraindications to a retro­peritoneal approach include:
1) Tumors larger than 7 cm – it can be difficult
to create an adequate working space with a tumor this large
2) Body mass index >45 – in morbidly obese
patients, it is often difficult to create enough room between the table and the patient to accommodate the large pannus. In these situations, the pannus and intraabdominal fat push onthe retroperitoneal space, collap­sing it.
3) Increased ocular pressures – prone position-
ing can increase the intraocular and intraor­bital pressures and cause pressure on the optic nerve and in extreme cases blindness. This effect is typically only seen in opera­tions lasting many, many hours.
4) Need to explore the rest of the abdomen
(such as examining the liver for metastases).
Whether or not suspected adrenocortical can­cers or malignant pheochromocytoma should be removed laparoscopically by any means is a controversial topic. With increased experience and laparoscopic skill, the once inviolate rule of removing adrenal cancers through an open inci­sion has been challenged. As with other areas where laparoscopy seems to improve oncologic outcomes, laparoscopic resection of primary adrenal cancers may become the norm. One of the few remaining absolute contraindications for abdominal laparoscopy is a disorder that precludes abdominal insufflation (e.g., severe lung or cardiac disease). However, with the lim­ited intrusion on the diaphragm that results from retroperitoneal insufflation, this limitation is only relatively applicable to the retroperito­neal technique. Certainly contraindications to increased venous pressure or decreased venous return (such as cranial hypertension) still apply for retroperitoneal right adrenalectomy since the inferior vena cava is compressed, but may
not applyto retroperitoneal left adrenalectomy. Giebler et al. studied the hemodynamic changes with retroperitoneal insufflation and found that hemodynamic changes do occur (increased central venous pressure, cardiac output,meanarterialpressure,andmeanpul­monary arterial pressure), but that these changes had no apparent adverse effects [17]. The one absolute contraindication for laparo­scopic retroperitoneal adrenalectomy is uncor­rectable coagulopathy.
Technique
Patient Positioning
The patient is first intubated on a stretcher and intravenous access and monitoring is obtained as appropriate. A urinary catheter is inserted. Two noncompressible bolsters are placed on the operating table of sufficient size to allow the pannus to lay elevated off the table. One bolster is placed at the joint in the bed where the lower extremity section meets the lower torso section. The hips will rest on this bolster. The second bolster is placed approximately at the level of the lower ribcage. Leg extensions are secured to the table. The patient is then placed in the prone position on the operating table with the hips and chest on the appropriate bol­ster. The patient should be flush to the side of the table. At this point, it is important to insure that the pannus is elevated off the table and that the bolster does not compress the breasts. The bed is then flexed at the junction of the upper and lower torso sec­tions (approximately 308)andatthejunction of the lower torso and lower extremity sec­tions (approximately 458) to position the lower back in a completely horizontal posi­tion. It is crucial to have the lower back in a completely neutral position to allow for full expansion of the retroperitoneal space. The leg extensions are then positioned horizontal to the floor to help prevent the patient from slipping caudally on the table. The arms are flexed at the elbows. All pressure points are padded generously and the skin is protected while the patient is appropriately secured in place (see Fig. 34.1).
454
ENDOCRINE SURGERY
Fig. 34.1. Patient positioning.
Port Placement
Three ports are placed in a rough line based on the inferior costal margin. The middle most port is placed just lateral to the paraspinous muscles and the lateral port is placed as far laterally as possible. These ports are 5-mm ports that are placed under direct palpation. The middle port lies halfway between the lateral and the medial ports and is the first port placed. This port is placed by first making a 1.5-cm incision just inferior to the costal margin and then bluntly entering the retroperitoneal space with a Met­zenbaum scissor. Spreading with the scissors expands this site of entry. Using a finger, the retroperitoneal space is then developed bluntly both medially and laterally so that the remain­ing ports may be placed safely using direct pal­pation. The medial port incision is placed approximately 4–5 cm caudal to the inferior margin of rib 12. The port is then placed into the retroperitoneal space on a bias or angle just inferior to rib 12. A 10-mm port with a ‘‘donut’’ balloon is placed into the middle port site.
Dissection of the Retroperitoneal Space
After insufflation to a pressure of 15 mm Hg, the camera is introduced into the medial port and
using a grasper in the lateral port, the Gerota’s fascia is entered bluntly. Once Gerota’s fascia is entered, the peri-adrenal and peri-renal fat should be swept anteriorly (i.e., toward the table) staying in the filmy posterior attach­ments. This dissection is carried laterally to reveal the peritoneum, medially to uncover the paraspinous muscles, and toward the apex where the paraspinous muscle and peritoneum meet. Once the medial port site is free of sur­rounding tissue, the camera is moved to this port and another instrument is introduced into the medial port. At this point, the superior pole of the kidney is identified. Starting laterally, the connections between the adrenal gland and the superior pole of the kidney are divided. This dissection is carried toward the renal hilum and along the cranial half of the anterior surface of the kidney so that the kidney may be retracted inferiorly and medially. This retrac­tion of the kidney facilitates identification and ligation of the adrenal vein. During the course of this dissection, inferior adrenal arteries may be encountered and should be ligated with a pur­pose-made sealing device or electrocautery if the vessel is small enough. The filmy plane between the adrenal gland and the paraspinous muscles medially should be dissected with
455
LAPAROSCOPIC RETROPERITONEAL ADRENALECTOMY
careful blunt and sharp dissection to expose the inferior phrenic vein on the left and the inferior vena cava on the right. During the course of this dissection, middle and superior adrenal arteries may be encountered and should also be ligated and divided.
Identification and Ligation of the Adrenal Vein
Right Adrenalectomy (Fig. 34.2)
Once the inferior vena cava is identified, the adrenal vein typically enters the adrenal gland at about the midpoint and on its anterior sur­face (i.e., closer to the table). The adrenal vein may be ligated and divided between clips or with a purpose-made sealing device.
Fig. 34.3. Left adrenal vein anatomy.
Left Adrenalectomy (Fig. 34.3)
The inferior phrenic vein may be traced toward the renal hilum to identify the adrenal vein. Alternatively, the left adrenal vein may be iden­tified from lateral to medial as the kidney is rotated inferiorly and medially. The left adrenal gland often has a tongue of tissue extending along or caudal to the adrenal vein. It is impor­tant to fully dissect out this extension of the gland. The left adrenal vein may be divided in the same manner as the right adrenal vein. The phrenic vein can usually be left intact.
Removal of the Adrenal Gland
Once the adrenal vein is ligated, the adrenal gland may be separated from the filmy
attachments to the peritoneum using a combi­nation of blunt and sharp dissection. Staying in this avascular plane facilitates removal of all the periadrenal fat and avoids rupture of the cap­sule. The specimen is placed in an extraction bag and removed. The 10-mm port site typically does not need to be enlarged to allow for removal. The port is replaced and the retroper­itoneal space is inspected under decreased pres­sure for hemostasis. The ports are removed and the 10 mm port site fascia is closed with an absorbable figure of eight stitch. The skin is closed with subcuticular stitches.
Postoperative Care
The postoperative care of the patient is dictated by the pathology of the tumor and is covered elsewhere in this book. The urinary catheter may be removed 4–6 h postoperatively. The patient should be ambulating and eating a reg­ular diet the day of the operation.
Outcomes
Fig. 34.2. Right adrenal vein anatomy.
As with the laparoscopic lateral transabdom­inal approach, complications after this opera­tion are not common. In the largest series to date, the incidence of incisional hernia, pneu­mothorax, and wound infection were all less than 1%. Approximately 8% of patients will experience hypesthesia or abdominal wall lax­ity. However, these are almost universally temporary findings.
456
ENDOCRINE SURGERY
Conclusion
Laparoscopic retroperitoneal adrenalectomy is a safe, fast, and efficient means of resecting the adrenal gland in most patients. The major benefits of this technique over the laparoscopic lateral transabdominal approach include shorter opera­tive times, avoidance of intraabdominal adhesions, and potentially fewer complications. Relative con­traindications to this technique include tumor size over 7 cm, body mass index greater than 45, and preexisting increased intraocular or intraorbital pressures. This technique should be part of the armamentarium of endocrine surgeons caring for patients with adrenal disease.
References
1. Whittle DE, Schroeder D, Purchas SH, et al. Laparo­scopic retroperitoneal left adrenalectomy in a patient with Cushing’s syndrome. Aust NZ J Surg. 1994;64(5):375–6.
2. WalzMK,AlesinaPF,WengerFA,etal.Posteriorretro­peritoneoscopic adrenalectomy–results of 560 procedures in 520 patients. Surgery. 2006;140(6):943–8; discussion 948–50.
3. Gaur DD. Retroperitoneal surgery of the kidney, ureter and adrenal gland. Endosc Surg Allied Technol. 1995;3(1):3–8.
4. Heintz A, Junginger T. Technique and results of the retroperitoneoscopic adrenalectomy via a lumbar approach. Langenbecks Arch Surg. 1998;383(3–4):286–8.
5. Walz MK, Peitgen K, Hoermann R,et al. Posterior retro­peritoneoscopy as a new minimally invasive approach for adrenalectomy: results of 30 adrenalectomies in 27 patients. World J Surg. 1996;20(7):769–74.
6. Morris L, Ituarte P, Zarnegar R, et al. Laparoscopic adrenalectomy after prior abdominal surgery. World J Surg. 2008;32(5):897–903.
7. Henry JF, Defechereux T, Raffaelli M, et al. Complica­tions of laparoscopic adrenalectomy: results of 169 con­secutive procedures. World J Surg. 2000;24(11):1342–6.
8. Terachi T, Matsuda T, Terai A, et al. Transperitoneal laparoscopic adrenalectomy: experience in 100 patients. J Endourol. 1997;11(5):361–5.
9. Zeh HJ, 3rd, Udelsman R. One hundred laparoscopic adrenalectomies: a single surgeon’s experience. Ann Surg Oncol. 2003;10(9):1012–7.
10. Guazzoni G, Montorsi F, Bocciardi A, et al. Transper­itoneal laparoscopic versus open adrenalectomy for benign hyperfunctioning adrenal tumors: a comparative study. J Urol. 1995;153(5):1597–600.
11. Prinz RA. A comparison of laparoscopic and open adre­nalectomies. Arch Surg. 1995;130(5):489–92; discussion 492–4.
12. Miyake O, Yoshimura K, Yoshioka T, et al. Laparoscopic adrenalectomy. Comparison of the transperitoneal and retroperitoneal approach. Eur Urol. 1998;33(3):303–7.
13. Gagner M, Pomp A, Heniford BT, et al. Laparoscopic adrenalectomy: lessons learned from 100 consecutive pro­cedures. Ann Surg. 1997;226(3):238–46; discussion 246–7.
14. Walz MK, Alesina PF, Wenger FA, et al. Laparoscopic and retroperitoneoscopic treatment of pheochromocy­tomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg. 2006;30(5):899–908.
15. Walz MK, Gwosdz R, Levin SL, et al. Retroperitoneo­scopic Adrenalectomy in Conn’s Syndrome Caused by Adrenal Adenomas or Nodular Hyperplasia. World J Surg. 2008;32(5):847–53.
16. Uchida M, Imaide Y, Yoneda K, et al. [Endoscopic adre­nalectomy by retroperitoneal approach for primary aldosteronism]. Hinyokika Kiyo. 1994; 40(1):43–6.
17. Giebler RM, Walz MK, Peitgen K, Scherer RU. Hemo­dynamic changes after retroperitoneal CO2 insufflation for posterior retroperitoneoscopic adrenalectomy. Anesth Analg. 1996;82(4):827–31.
Section IV
Pancreas
“This page left intentionally blank.”
35

Pancreas: Embryology, Anatomy, and Physiology

Tracy-Ann Moo, Rasa Zarnegar and Laurent Brunaud
Embryology of the Pancreas
In the fourth week of embryonic life, the pancreas begins to develop from endodermal structures within the primitive duodenum. The pancreas arises as two separate buds, which subsequently fuse to form a single organ (Fig. 35.1). The dorsal pancreatic bud arises from an evagination of the foregut endoderm and begins to grow into the dorsal mesentery. The ventral pancreatic bud develops from the ventral endoderm of the hepa­tic diverticulum. Development of the ventral bud occurs by default in endodermal areas where liver induction by fibroblast growth factor (FGF) does not take place. Signaling via activin and FGF originating from the apposing noto­chord influences the development of the dorsal bud[1].Bythefifthweek,thegrowthofthe dorsal bud has surpassed that of the ventral bud. At this time the duodenum begins to rotate, bringing the ventral pancreas along with the common bile duct behind it into contact with the dorsal bud (Fig. 35.2A). By the sixth week, both buds have fused so that the dorsal bud becomes the anterior part of the head, body, andtailofthepancreas,whiletheventralbud forms the posterior head and uncinate process (Fig. 35.2B).
After fusion of the two pancreatic buds, the two ducts which have developed within each bud begin to anastomose. Usually, the distal segment of the ventral pancreatic duct extends
toward the dorsal duct to form this anastomosis. The duct of the ventral bud then persists as the main pancreatic duct (duct of Wirsung) while the dorsal duct regresses. In up to 60% of the population, the dorsal duct persists as an acces­sory pancreatic duct (duct of Santorini) [2]. Over the following weeks the main duct elon­gates into the surrounding mesenchyme giving rise to secondary ducts, which further elongate to form terminal ductules. These terminal ducts are arranged in cell clusters and will form the future pancreatic acini, which performs the exo­crine functions of the pancreas. At about week 12, signaling from surrounding mesenchyme promotes the differentiation of the acini. As the acini differentiate they begin to produce low levels of hydrolic enzyme. By birth, these acini will have attained a highly differentiated state, possess an extensive network of protein synthesizing apparatus, and have the ability to store inactive digestive enzymes within cyto­plasmic zymogen granules.
The islets of Langerhans, the endocrine com­ponent of the pancreas, arise from epithelial cells along the pancreatic acini. These primitive endocrine cells subsequently proliferate into distinct cell clusters and migrate into the mesenchyme of the developing pancreas. In the tenth week angiogenesis begins within the mesenchyme; signals from the developing vas­culature cause these cells to develop along an endocrine lineage. Early endocrine cells
J.G.H. Hubbard et al. (eds.), Endocrine Surgery, Springer Specialist Surgery Series, DOI 10.1007/978-1-84628-881-4_35, Ó Springer-Verlag London Limited 2009
459